Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-023085
Date:2021-03-23
Issuer: SANGAMO THERAPEUTICS, INC (SGMO)
Original Submission Date:

Reporting Person:

LOEB GARY
C/O SANGAMO THERAPEUTICS, INC.
7000 MARINA BLVD BRISBANE, CA 94005

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-23 M 11,981 a $11.02 100,762 direct
COMMON STOCK 2021-03-23 S 11,981 d $13.10 88,781 direct
COMMON STOCK 2021-03-23 S 5,000 d $13.18 83,781 direct
COMMON STOCK 2021-03-23 S 543 d $13.17 83,238 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT-TO-BUY) 11.02 2021-03-23 deemed execution date M 11,981 (d) 2029-08-22 common stock 11,981 $11.02 238,019 direct
Footnotes
IDfootnote
f1 includes 33,335 shares of common stock issuable upon settlement of restricted stock units ("rsus") granted to the reporting person on february 25, 2020 that will vest in two remaining annual installments of 16,665 shares and 16,670 shares on february 25, 2022 and 2023 respectively, and 44,000 shares of common stock issuable upon settlement of rsus granted to the reporting person on february 25, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third anniversary of the date of grant. the vesting of all such rsus is subject to the reporting person's continuous service as defined in the issuer's amended and restated 2018 equity incentive plan, as amended (the "2018 eip, as amended"), through such dates and subject to acceleration as defined in the 2018 eip, as amended.
f2 the option vested as to 1/4 of the total grant amount upon completion of one (1) year of continuous service, as defined in the 2018 eip, as amended, by the reporting person, measured from the august 23, 2019 grant date, and the remainder vest and become exercisable in equal monthly installments for thirty-six months thereafter, subject to the reporting person's continuous service as defined in the 2018 eip, as amended, through each such vesting date and subject to acceleration as provided in the 2018 eip, as amended.

Elevate your investments